Chiari Malformations

1. Clinical Overview

Summary

Chiari malformations are a spectrum of congenital structural defects involving the posterior fossa and hindbrain, characterised by cerebellar tissue herniation through the foramen magnum into the spinal canal. Named after Austrian pathologist Hans Chiari (1891), these malformations represent developmental anomalies of the craniovertebral junction with significant clinical heterogeneity. [1,2]

The classification encompasses four types, though Type I and Type II account for the vast majority of clinical presentations:

Chiari Type I Malformation (CM-I)

• Most common in adults (though often diagnosed incidentally)
• Defined by cerebellar tonsillar descent ≥5mm below the foramen magnum on sagittal MRI
• Peak clinical presentation in the third to fourth decade
• Strongly associated with syringomyelia (60-80% of symptomatic cases)
• Characteristic symptom: occipital headache exacerbated by Valsalva manoeuvres (coughing, sneezing, straining, laughing)
• Many cases remain asymptomatic throughout life (prevalence 0.5-3.5% on MRI studies)
• Female predominance (F:M ratio approximately 3:1)

Chiari Type II Malformation (CM-II, Arnold-Chiari Malformation)

• Presents in infancy or early childhood
• Almost universally associated with myelomeningocele (spina bifida aperta)
• Involves herniation of cerebellar vermis, fourth ventricle, and brainstem
• Associated with hydrocephalus in 80-90% of cases
• Small posterior fossa with characteristic "crowding" of posterior fossa structures
• Often diagnosed prenatally on ultrasound (lemon sign, banana sign)
• More severe clinical course than Type I

Chiari Type III and IV are rare and severe malformations associated with high mortality. Type III involves herniation of cerebellum into an occipital or high cervical encephalocele. Type IV is characterised by cerebellar hypoplasia without herniation. [3,4]

Pathophysiological Mechanisms

The fundamental pathophysiology centres on obstruction of CSF flow at the craniocervical junction:

1. Tonsillar impaction at the foramen magnum creates a "cork-in-bottle" phenomenon
2. Valsalva manoeuvres transiently increase intracranial pressure → further tonsillar descent → sudden pressure spikes → characteristic headache
3. Chronic CSF flow obstruction → pressure dissociation between cranial and spinal subarachnoid spaces
4. Syrinx formation: abnormal CSF pulsation drives fluid into central canal of spinal cord → progressive cavitation (syringomyelia)
5. Brainstem compression → cranial nerve palsies, sleep apnoea, dysphagia
6. Spinal cord compression → myelopathy (upper motor neuron signs)

Type I is thought to result from a small posterior fossa (para-axial mesoderm underdevelopment), leading to "overcrowding" and downward herniation of normally developed cerebellar tonsils. [5,6]

Type II results from incomplete closure of the neural tube during early embryogenesis, with secondary effects on posterior fossa development. The chronic CSF leakage through the myelomeningocele causes downward traction and herniation of hindbrain structures. [7]

Clinical Significance

• High-yield for neurology and neurosurgery examinations (MRCP, FRCS Neurosurgery)
• Classic presentation ("cough headache") is a frequent OSCE scenario
• Syringomyelia association provides opportunity for multi-level neurological examination findings
• Surgical decision-making (asymptomatic vs symptomatic management) is an important viva topic
• Differential diagnosis of headache and posterior fossa lesions

---

Key Facts

---

Clinical Pearls

"Cough Headache = Think Chiari": An occipital headache that worsens with coughing, straining, or laughing is pathognomonic for Chiari I malformation until proven otherwise. Immediate MRI brain and cervical spine is mandatory. [8]

"5mm is the Threshold": Cerebellar tonsils descending ≥5mm below the line from basion to opisthion (McRae line) on sagittal T1 MRI defines Chiari I. However, clinical symptoms do not always correlate with degree of descent—some patients with 3-4mm descent are highly symptomatic, while others with 10mm descent are asymptomatic. [1,2]

"Syrinx = Consequence, Not Cause": Syringomyelia (CSF-filled cavity within spinal cord) is a complication of Chiari I, not the primary pathology. It results from abnormal CSF pulsation dynamics. Successful posterior fossa decompression often leads to syrinx resolution over months to years. [9]

"Type II = Myelomeningocele = Hydrocephalus": Chiari II is part of a triad: neural tube defect (myelomeningocele) + hindbrain herniation + hydrocephalus. Almost all patients require VP shunt for hydrocephalus in infancy. [7]

"Asymptomatic Does Not Mean Benign—But Also Doesn't Always Need Surgery": Many Chiari I cases are incidental findings on MRI. Natural history studies show that most asymptomatic patients remain stable. Surgery is reserved for symptomatic patients or those with progressive syringomyelia. Prophylactic surgery for asymptomatic patients is not recommended. [10]

"Downbeat Nystagmus = Craniocervical Junction Pathology": Downbeat nystagmus (worsens on lateral gaze) is a classic sign of Chiari I and other foramen magnum lesions. It results from compression of the vestibulocerebellum and is often enhanced by convergence. [11]

"Don't Forget the Spine": Always image the entire spine (cervical + thoracic ± lumbar) in suspected Chiari, not just the brain. Syringomyelia can extend from cervical to lumbar cord, and multiple syrinxes can occur. MRI spine is mandatory preoperatively. [9]

---

2. Epidemiology

Prevalence and Incidence

The wide discrepancy between MRI prevalence and symptomatic disease reflects the fact that most Chiari I cases are asymptomatic. Large retrospective MRI studies have shown tonsillar ectopia ≥5mm in up to 1% of scans performed for unrelated reasons. [1,12]

---

Demographics

Age

• Chiari I: Bimodal distribution
  • "First peak: childhood (5-15 years)—often presents with headache, scoliosis"
  • "Second peak: young to middle-aged adults (25-45 years)—headache, syringomyelia symptoms"
  • Can be diagnosed at any age; increasingly found incidentally on MRI for trauma, headache
• Chiari II: Presents in infancy or detected prenatally

Sex

• Chiari I: Strong female predominance (F:M = 3:1 in symptomatic cases)
  • Reasons unclear; may relate to hormonal factors, smaller posterior fossa volume in females
• Chiari II: Equal sex distribution (1:1)

Geography and Ethnicity

• No strong geographic or ethnic predilection identified for Chiari I
• Chiari II incidence mirrors neural tube defect epidemiology:
  • Highest rates historically in Ireland, Wales, parts of China
  • Dramatic decline in countries with folic acid supplementation programmes (reduction of 50-70% in spina bifida rates) [13]

---

Risk Factors and Associations

Chiari Type I

Anatomical Risk Factors

• Small posterior fossa volume: Primary anatomical abnormality [5]
• Achondroplasia and other skeletal dysplasias (narrowed foramen magnum)
• Craniosynostosis (premature fusion of sutures → increased ICP → tonsillar herniation)
• Klippel-Feil syndrome (congenital fusion of cervical vertebrae)

Acquired Causes (Rare)

• Lumbar-peritoneal shunt: Chronic overdrainage → low spinal CSF pressure → "acquired" tonsillar descent
• Posterior fossa mass lesions: Tumours causing downward displacement
• Idiopathic intracranial hypertension: Chronically elevated ICP may cause tonsillar descent

Family History

• Most cases are sporadic
• Rare familial clustering reported (estimated 1-4% of cases)—suggests possible genetic susceptibility in subset of patients [14]

Chiari Type II

Primary Association: Myelomeningocele

• Virtually 100% of Chiari II patients have myelomeningocele (open spinal dysraphism)
• Pathophysiological link: failure of neural tube closure (days 21-28 of gestation)

Maternal Risk Factors for Neural Tube Defects (and hence Chiari II)

• Low folate status (most important modifiable risk factor)
• Diabetes mellitus (3-fold increased risk)
• Anti-epileptic drugs (particularly valproate, carbamazepine)
• Obesity (unclear mechanism; may relate to folate metabolism)
• Hyperthermia in early pregnancy (fever, sauna use)
• Previous affected pregnancy (recurrence risk 2-5%)

Protective Factors

• Periconceptional folic acid supplementation (400-800 mcg daily)—reduces NTD risk by 50-70% [13]

---

Associated Conditions

---

Natural History

Chiari Type I

• Asymptomatic patients: Majority (> 80%) remain stable over years; only ~10% become symptomatic [10]
• Symptomatic patients: Symptoms may fluctuate but generally show gradual progression over months to years
• Syringomyelia: If present, tends to progress without surgical intervention; may stabilise spontaneously in ~10%
• Pregnancy: May exacerbate symptoms (increased intra-abdominal pressure, Valsalva during labour); however, most women with Chiari I tolerate pregnancy well

Chiari Type II

• Infant mortality: 10-15% in first year of life (apnoea, brainstem dysfunction)
• Long-term prognosis: Depends on severity of myelomeningocele, hydrocephalus management, and associated comorbidities
• Many patients survive to adulthood with good functional status if complications managed appropriately

---

3. Aetiology and Pathophysiology

Embryological Development

Normal Posterior Fossa Development

The posterior fossa is formed by the following embryological processes:

1. Para-axial mesoderm gives rise to the occipital bone and foramen magnum (weeks 4-8 of gestation)
2. Rhombencephalon (hindbrain) differentiates into metencephalon (pons, cerebellum) and myelencephalon (medulla)
3. Cerebellar development: begins at ~30 days, with migration and foliation continuing into postnatal life
4. The fourth ventricle and foramen magnum must accommodate hindbrain structures

Normal cerebellar tonsils lie above the foramen magnum (McRae line: basion to opisthion). Mild tonsillar descent (less than 5mm) can be a normal variant in children and adolescents. [2]

---

Pathogenesis of Chiari Type I

The precise aetiology of CM-I remains debated, but the "small posterior fossa" hypothesis is most widely accepted. [5,6]

Primary Mechanism: Para-axial Mesoderm Underdevelopment

• Inadequate development of the occipital bone → small, shallow posterior fossa
• Normally sized cerebellum and brainstem become "overcrowded"
• Cerebellar tonsils are displaced downward through the foramen magnum (like "squeezing toothpaste from a tube")
• This creates a mismatch between posterior fossa volume and neural tissue volume

Morphometric MRI Studies have shown:

• Reduced posterior fossa volume (by 10-15% compared to controls)
• Reduced supraoccipital bone length
• Shallow posterior fossa with more horizontal tentorium
• Normal or slightly enlarged cerebellum (ruling out cerebellar overgrowth as primary cause) [5]

Secondary Consequences

• Tonsillar descent → foramen magnum obstruction
• Obstruction to CSF flow → altered CSF dynamics
• Abnormal CSF pulsations → syrinx formation

---

Pathogenesis of Chiari Type II (Arnold-Chiari Malformation)

CM-II is fundamentally a consequence of neural tube defect (myelomeningocele). [7]

Primary Pathology: Failure of Neural Tube Closure

• Neural tube normally closes by day 28 of gestation
• Failure of closure in the spinal region → open spinal dysraphism (myelomeningocele)
• Chronic CSF leakage from the open neural tube during fetal development

Unified Theory (McLone-Knepper Hypothesis) [16]

1. CSF leaks out through myelomeningocele defect in utero
2. Reduced CSF volume in the ventricular system
3. Failure of ventricular distension → fourth ventricle does not expand normally
4. Small posterior fossa develops secondarily (reduced "hydrostatic pressure" stimulus for bone growth)
5. Hindbrain structures (cerebellar vermis, tonsils, brainstem) herniate downward through foramen magnum
6. Result: crowded, malformed posterior fossa with herniated contents

Associated Features

• Beaked tectum (fusion of colliculi)
• Medullary kink (Z-shaped deformity of medulla)
• Towering cerebellum (upward herniation through tentorial incisura)
• Hydrocephalus: develops due to aqueductal stenosis and fourth ventricular outlet obstruction

---

CSF Flow Dynamics and Syringomyelia

A key complication of Chiari I is syringomyelia—a fluid-filled cavity within the spinal cord parenchyma.

Normal CSF Flow Physiology

• Cardiac systole → arterial pulsation → brain expansion → CSF ejection from cranium into spinal canal
• Diastole → brain relaxation → CSF returns to cranium
• This creates bidirectional pulsatile flow through the foramen magnum (visible on cine MRI)

Pathological CSF Flow in Chiari I

• Cerebellar tonsils act as a "piston" at the foramen magnum
• Obstruction of posterior CSF space (cisterna magna is obliterated)
• Pressure dissociation: cranial CSF pressure exceeds spinal CSF pressure during systole
• Abnormal pressure waves transmitted to cord surface
• Fluid is driven into the central canal of the spinal cord (which normally obliterates after childhood)
• Progressive fluid accumulation → syrinx formation and enlargement [9]

Syrinx Characteristics

• Most commonly cervical (60%) or cervicothoracic (30%)
• May extend entire length of cord ("holocord syrinx")
• Can be multiloculated (multiple septations)
• Syrinx fluid is similar to CSF but slightly higher protein content

Clinical Consequences of Syringomyelia

• Dissociated sensory loss: damage to decussating spinothalamic fibres in anterior commissure → loss of pain and temperature sensation in cape-like distribution (shoulders, arms, upper trunk), while dorsal column modalities (vibration, proprioception) remain intact
• Lower motor neuron signs in upper limbs (weakness, wasting, hyporeflexia)—due to anterior horn cell damage
• Upper motor neuron signs in lower limbs (spasticity, hyperreflexia, Babinski sign)—due to corticospinal tract compression
• Charcot joint (neuropathic arthropathy) in shoulders (rare)—due to loss of pain sensation

---

Brainstem and Cranial Nerve Compression

Tonsillar herniation may compress the medulla oblongata and lower cranial nerves.

Clinical Manifestations

• Dysphagia, dysphonia, aspiration: CN IX, X compression
• Tongue weakness, atrophy: CN XII compression
• Sleep apnoea: compression of respiratory centres in medulla [15]
  • Central apnoea (loss of respiratory drive)
  • Obstructive apnoea (vocal cord paralysis)
• Syncope, drop attacks (rare): vertebrobasilar insufficiency or sudden CSF pressure changes

---

Molecular and Genetic Insights

While most Chiari I cases are sporadic, rare familial clustering has prompted genetic investigation.

Candidate Genes and Pathways (Research Ongoing)

• Genes involved in bone development (posterior fossa formation):
  • COL1A1, COL1A2 (collagen defects → connective tissue disorders → Chiari I)
• Genes involved in neural tube closure (Chiari II):
  • MTHFR (methylenetetrahydrofolate reductase)—folate metabolism
  • PAX3, VANGL1, VANGL2—neural tube closure genes
• No single "Chiari gene" identified; likely polygenic or multifactorial [14]

---

4. Clinical Presentation

The clinical presentation of Chiari malformations is highly variable, ranging from asymptomatic incidental findings to severe, life-threatening brainstem dysfunction.

---

Chiari Type I: Clinical Syndromes

Syndrome 1: Headache (Most Common Presentation)

Characteristics of Chiari Headache [8]

• Location: Occipital, suboccipital, or upper cervical (back of head and neck)
• Quality: Pressure-like, "fullness," or sharp stabbing pain
• Duration: Seconds to minutes (brief episodes), or constant dull ache
• Exacerbating factors (pathognomonic):
  • "Valsalva manoeuvres: coughing, sneezing, straining, laughing, lifting heavy objects"
  • Bending forward
  • Physical exertion
• Associated symptoms:
  • Neck stiffness
  • Photophobia (less common than in migraine)
  • Nausea (uncommon)
  • Visual blurring (transient)

Mechanism: Valsalva → increased intrathoracic/intra-abdominal pressure → increased venous pressure → transiently increased intracranial pressure → tonsillar impaction at foramen magnum → acute pressure spike → headache

Differential Diagnosis of "Cough Headache"

• Primary cough headache (benign; diagnosis of exclusion)
• Chiari malformation (most important structural cause)
• Posterior fossa tumour
• Basilar invagination
• Idiopathic intracranial hypertension

Rule: Any patient with cough-induced headache requires MRI brain and cervical spine to exclude Chiari I. [8]

---

Syndrome 2: Syringomyelia (60-80% of Symptomatic Chiari I)

Classic Presentation: "Cape-Like" Dissociated Sensory Loss

• Loss of pain and temperature sensation over shoulders, arms, upper chest (spinothalamic tract)
• Preserved vibration and proprioception (dorsal columns intact)
• Distribution: bilateral, symmetrical, cape-like or suspended (sparing lower segments initially)

Motor Symptoms

• Upper limbs (lower motor neuron):
  • Weakness (difficulty with fine motor tasks—buttoning shirts, writing)
  • Muscle wasting (intrinsic hand muscles, thenar/hypothenar eminences)
  • Hyporeflexia or areflexia
• Lower limbs (upper motor neuron):
  • Spasticity, hyperreflexia
  • Extensor plantar response (Babinski sign)
  • Gait disturbance (spastic or ataxic)

Autonomic Dysfunction

• Bladder dysfunction (urgency, frequency, incontinence)—late feature
• Horner syndrome (if syrinx extends to C8-T1 sympathetic fibres)

Other Syrinx-Related Features

• Scoliosis (10-25% of cases, especially in children/adolescents)
• Neuropathic pain (dysaesthetic, burning)
• Charcot joint (rare; shoulder most common)

Progression: Syringomyelia typically progresses slowly over years, but sudden deterioration can occur with trauma or during pregnancy.

---

Syndrome 3: Brainstem Compression

Lower Cranial Nerve Palsies

• Dysphagia (difficulty swallowing)
• Dysarthria (slurred speech)
• Dysphonia (hoarse voice)
• Aspiration (risk of pneumonia)
• Tongue weakness (CN XII)

Central Symptoms

• Nystagmus (especially downbeat nystagmus)—classic sign of foramen magnum pathology [11]
• Oscillopsia (visual blurring with head movement)
• Vertigo, dizziness
• Ataxia (cerebellar or posterior column involvement)
• Drop attacks (sudden loss of tone in legs without loss of consciousness)—rare but dramatic

Sleep-Disordered Breathing [15]

• Central sleep apnoea (medullary compression → loss of respiratory drive)
• Obstructive sleep apnoea (vocal cord paralysis, pharyngeal collapse)
• Symptoms: daytime somnolence, morning headaches, snoring, witnessed apnoeas
• May be life-threatening if severe

---

Syndrome 4: Spinal Cord Compression (Myelopathy)

• Upper motor neuron signs: spasticity, hyperreflexia, clonus, Babinski
• Gait disturbance: spastic, scissoring gait
• Sensory level (rare; more typical of intrinsic cord lesions)

---

Chiari Type II: Clinical Syndromes

Chiari II presents in infancy or early childhood, often with life-threatening complications.

Neonatal Presentation

Stridor and Vocal Cord Paralysis

• Bilateral vocal cord paralysis (10-20% of Chiari II)—due to nucleus ambiguus compression
• High-pitched inspiratory stridor
• May require tracheostomy if severe

Apnoea and Respiratory Failure [7]

• Central apnoea (medullary compression)
• Most dangerous complication—can cause sudden death
• Requires close monitoring in neonatal period

Dysphagia and Feeding Difficulties

• Poor suck and swallow coordination
• Aspiration risk
• May require nasogastric or gastrostomy feeding

Associated Myelomeningocele

• Visible spinal defect (usually lumbosacral)
• Lower limb paralysis (severity depends on level of lesion)
• Neurogenic bladder and bowel

---

Hydrocephalus (80-90% of Chiari II)

Clinical Features in Infants

• Increasing head circumference
• Bulging fontanelle
• Sunsetting eyes (upward gaze palsy)
• Irritability, vomiting
• Requires VP shunt in most cases

---

Later Childhood Presentation

• Headache (less common than in Chiari I)
• Syringomyelia (20-40%)—may develop years after birth
• Scoliosis (multifactorial: syrinx, tethered cord, spinal dysraphism)
• Cognitive impairment (related to hydrocephalus, not Chiari itself)

---

Incidental (Asymptomatic) Chiari I

Prevalence: 0.5-3.5% of MRI scans show tonsillar ectopia ≥5mm [1,12]

Management Dilemma

• Most asymptomatic patients remain asymptomatic
• ~10% may become symptomatic over 5-10 years
• No indication for prophylactic surgery
• Requires clinical correlation—minor symptoms may be attributed to Chiari only if typical

Recommendation: Asymptomatic patients should have:

• Clinical review (annual or if new symptoms)
• Repeat MRI (every 1-2 years initially, then less frequently if stable)—to assess for syrinx development

---

5. Clinical Examination

General Inspection

• Scars: Posterior fossa decompression scar (midline, suboccipital), VP shunt scar (behind ear), myelomeningocele repair scar (midline spine)
• Head size: Macrocephaly (hydrocephalus in Chiari II)
• Scoliosis: Visible spinal curvature (syrinx, tethered cord)

---

Neurological Examination: Structured Approach

Cranial Nerves

Downbeat Nystagmus

• Fast phase beats downward
• Enhanced by lateral gaze or convergence
• Mechanism: compression of flocculonodular lobe of cerebellum (vestibulocerebellum)
• Causes: Chiari malformation, basilar invagination, spinocerebellar ataxia, lithium toxicity

---

Upper Limbs (Syringomyelia Signs)

Inspection

• Wasting: Intrinsic hand muscles, forearm muscles (anterior horn cell damage)
• Scars: Burns, painless injuries (loss of pain sensation)
• Scoliosis: Cervicothoracic curve

Tone

• Reduced or normal (lower motor neuron involvement)

Power

• Weakness: Distal > proximal (hand grip, finger abduction/adduction)
• Distribution: bilateral, often asymmetric

Reflexes

• Hyporeflexia or areflexia in upper limbs (anterior horn cell damage)
• Inverted radial reflex: Finger flexion instead of elbow extension on tapping brachioradialis tendon (classic sign of C5/6 lesion)

Sensation

• Dissociated sensory loss (pathognomonic):
  • Loss of pain (pinprick) and temperature over shoulders, upper arms, upper chest (cape-like distribution)
  • Preserved vibration and proprioception (dorsal columns intact)
• Distribution: Bilateral, often asymmetric, "suspended" (does not reach hands initially)

---

Lower Limbs (Myelopathy/UMN Signs)

Gait

• Spastic gait (stiff, scissoring)
• Ataxia (cerebellar or posterior column involvement)

Tone

• Increased (spasticity)
• Clonus at ankle

Power

• Variable weakness (pyramidal pattern—extensors > flexors)

Reflexes

• Hyperreflexia (knee, ankle jerks)
• Extensor plantar response (Babinski sign)

Sensation

• Usually intact, unless extensive syrinx

---

Cerebellar Examination

• Nystagmus (downbeat)
• Dysarthria (scanning speech)
• Dysdiadochokinesia
• Intention tremor, past-pointing (finger-nose test)
• Gait ataxia (wide-based, unsteady)

---

Spine Examination

• Scoliosis: Thoracic or cervicothoracic curvature (syrinx, tethered cord)
• Myelomeningocele scar: Midline lumbosacral defect (Chiari II)

---

Examination Viva: Model Answer

Viva Question: "This 32-year-old woman has occipital headache. Please examine her neurological system."

Candidate Approach:

1. Introduction and Inspection:

   • "I would like to introduce myself and obtain consent. I will look for any scars suggestive of previous neurosurgery, such as a suboccipital decompression or VP shunt."

2. Cranial Nerve Examination:

   • "I will perform a full cranial nerve examination, paying particular attention to eye movements looking for downbeat nystagmus, and lower cranial nerves (IX, X, XII) for signs of brainstem compression."

3. Upper Limb Examination:

   • "I will assess for signs of syringomyelia:
     • Inspection for muscle wasting (intrinsic hand muscles)
     • Sensory examination for dissociated sensory loss (loss of pain and temperature with preserved vibration and proprioception) in a cape-like distribution
     • Reflexes for hyporeflexia or inverted radial reflex
     • Motor examination for LMN weakness"

4. Lower Limb Examination:

   • "I will assess for upper motor neuron signs: increased tone, hyperreflexia, clonus, Babinski sign, and spastic gait."

5. Cerebellar Examination:

   • "I will assess for cerebellar signs: nystagmus, dysarthria, dysdiadochokinesia, intention tremor, gait ataxia."

6. Spine Examination:

   • "I will inspect the spine for scoliosis and any scars."

7. Summary:

   • "My examination findings are consistent with Chiari I malformation with syringomyelia. I would like to arrange an MRI brain and whole spine to confirm the diagnosis and assess the extent of tonsillar herniation and syrinx."

---

6. Differential Diagnosis

The differential diagnosis of Chiari malformations depends on the presenting syndrome.

---

Differential Diagnosis of Occipital Headache Worsened by Valsalva

---

Differential Diagnosis of Syringomyelia

---

Differential Diagnosis of Downbeat Nystagmus

---

Differential Diagnosis of Stridor in Infancy (Chiari II)

---

7. Investigations

First-Line Imaging: MRI Brain and Cervical Spine

Gold Standard Investigation for Chiari Malformations [1,2]

MRI Protocol

• Sequences:
  • "Sagittal T1-weighted: Best for measuring tonsillar descent"
  • "Sagittal T2-weighted: Shows CSF (bright), syrinx (bright), tonsillar herniation"
  • "Axial T2-weighted: Assesses brainstem compression, syrinx extent"
  • "Cine phase-contrast MRI (optional): Assesses CSF flow dynamics at foramen magnum"

Key Measurements and Findings

Chiari Type I

Grading of Tonsillar Descent (Clinical Correlation is Key)

• 5-10mm: Mild descent (may be asymptomatic)
• 10-15mm: Moderate descent
• > 15mm: Severe descent (higher likelihood of symptoms)

However: Degree of descent does not correlate with severity of symptoms. Some patients with 5mm descent are highly symptomatic, while others with 15mm descent are asymptomatic. [1]

---

Chiari Type II

Prenatal Ultrasound Features (Detected in 70-90% of Cases) [17]

• Lemon sign: Scalloping of frontal bones (second trimester)
• Banana sign: Abnormal curved cerebellum (obliterated cisterna magna)
• Ventriculomegaly
• Myelomeningocele (cystic spinal lesion)

---

Second-Line Imaging

---

Functional Investigations

---

Neurophysiology (Rarely Required)

---

Lumbar Puncture

Generally AVOIDED in Chiari Malformations

• Risk of tonsillar herniation (rapid reduction in spinal CSF pressure can cause acute brainstem compression—"coning")
• Exception: If hydrocephalus suspected, LP may be performed after imaging confirms no mass lesion or herniation

---

8. Classification and Staging

Classification of Chiari Malformations [3,4]

Note: Type III and IV are extremely rare and often considered distinct entities rather than part of the Chiari spectrum.

---

Grading of Syringomyelia (Based on MRI)

Extent (Craniocaudal)

• Localized: Single segment (e.g., C4-C6)
• Regional: Multiple contiguous segments (e.g., C2-T4)
• Holocord: Entire spinal cord (cervical to lumbar)

Diameter (Axial)

• Mild: less than 25% of cord diameter
• Moderate: 25-50% of cord diameter
• Severe: > 50% of cord diameter

Configuration

• Central: Syrinx centered in cord (most common)
• Eccentric: Syrinx off-center
• Multiloculated: Multiple septations within syrinx

---

9. Management

Management of Chiari malformations requires careful patient selection, with surgery reserved for symptomatic patients or those with progressive syringomyelia. Asymptomatic patients are observed.

---

General Principles

1. Asymptomatic Chiari I: Observation (no surgery)
2. Symptomatic Chiari I: Surgical decompression
3. Chiari II with hydrocephalus: VP shunt first-line
4. Chiari II with brainstem compression: Posterior fossa decompression (controversial)

---

Management Algorithm

┌────────────────────────────────────────────────────────────────┐
│         CHIARI MALFORMATION MANAGEMENT ALGORITHM                │
├────────────────────────────────────────────────────────────────┤
│                                                                │
│  STEP 1: CONFIRM DIAGNOSIS                                     │
│  • MRI brain and cervical spine (whole spine if syrinx)        │
│  • Measure tonsillar descent (≥5mm)                            │
│  • Assess for syringomyelia                                    │
│                                                                │
│  STEP 2: ASSESS SYMPTOMS                                       │
│  • Headache (Valsalva-induced)?                                │
│  • Syringomyelia symptoms (dissociated sensory loss, weakness)?│
│  • Brainstem symptoms (dysphagia, sleep apnoea)?               │
│  • Myelopathy (UMN signs)?                                     │
│                                                                │
│  STEP 3: STRATIFY MANAGEMENT                                   │
│                                                                │
│  ┌─────────────────────────────────────────┐                  │
│  │ ASYMPTOMATIC CHIARI I                   │                  │
│  │ (Incidental Finding)                    │                  │
│  ├─────────────────────────────────────────┤                  │
│  │ • Observation (no surgery)              │                  │
│  │ • Patient education (symptoms to watch) │                  │
│  │ • Repeat MRI:                           │                  │
│  │   - 1 year (baseline)                   │                  │
│  │   - Then every 2-3 years if stable      │                  │
│  │ • Review if new symptoms develop        │                  │
│  └─────────────────────────────────────────┘                  │
│                                                                │
│  ┌─────────────────────────────────────────┐                  │
│  │ SYMPTOMATIC CHIARI I                    │                  │
│  │ (Headache, Syrinx, Brainstem Symptoms)  │                  │
│  ├─────────────────────────────────────────┤                  │
│  │ CONSERVATIVE TRIAL (Optional)           │                  │
│  │ • Analgesia (paracetamol, NSAIDs)       │                  │
│  │ • Avoid Valsalva triggers               │                  │
│  │ • Trial for 3-6 months                  │                  │
│  │                                         │                  │
│  │ SURGICAL INDICATIONS:                   │                  │
│  │ • Persistent, disabling headache        │                  │
│  │ • Progressive syringomyelia             │                  │
│  │ • Neurological deficit (motor, sensory) │                  │
│  │ • Sleep apnoea (brainstem compression)  │                  │
│  │ • Significant QoL impairment            │                  │
│  │                                         │                  │
│  │ PROCEDURE:                              │                  │
│  │ • Posterior fossa decompression (PFD)   │                  │
│  │   - Suboccipital craniectomy            │                  │
│  │   - C1 posterior arch removal           │                  │
│  │   - +/- Duraplasty (intradural vs       │                  │
│  │     extradural)                         │                  │
│  └─────────────────────────────────────────┘                  │
│                                                                │
│  ┌─────────────────────────────────────────┐                  │
│  │ CHIARI TYPE II                          │                  │
│  ├─────────────────────────────────────────┤                  │
│  │ HYDROCEPHALUS (80-90% of cases):        │                  │
│  │ • VP shunt (first-line)                 │                  │
│  │ • Monitor shunt function                │                  │
│  │                                         │                  │
│  │ SYMPTOMATIC BRAINSTEM COMPRESSION:      │                  │
│  │ • Stridor, apnoea, dysphagia            │                  │
│  │ • Posterior fossa decompression         │                  │
│  │   (controversial; high complication     │                  │
│  │   rate in infants)                      │                  │
│  │ • Multidisciplinary team input          │                  │
│  │   (paediatric neurosurgery, spina       │                  │
│  │   bifida team)                          │                  │
│  │                                         │                  │
│  │ MYELOMENINGOCELE REPAIR:                │                  │
│  │ • Surgical repair within 24-48 hours    │                  │
│  │   of birth                              │                  │
│  │ • Fetal surgery (in utero repair) may   │                  │
│  │   reduce need for VP shunt [18]         │                  │
│  └─────────────────────────────────────────┘                  │
│                                                                │
│  STEP 4: POST-OPERATIVE MONITORING                             │
│  • Repeat MRI at 6-12 months                                   │
│  • Assess syrinx resolution (may take years)                   │
│  • Monitor for complications (CSF leak, infection)             │
│  • Long-term follow-up (annual review)                         │
│                                                                │
└────────────────────────────────────────────────────────────────┘

---

Surgical Management: Posterior Fossa Decompression (PFD)

Indications for Surgery [10,19]

• Symptomatic Chiari I:
  • Persistent, disabling headache (not responding to conservative measures)
  • Progressive syringomyelia
  • Neurological deficit (motor weakness, sensory loss)
  • Brainstem compression (sleep apnoea, dysphagia, lower CN palsies)
  • Significant impairment of quality of life

Contraindications

• Asymptomatic Chiari I (observation only)
• Severe medical comorbidities precluding surgery
• Patient preference for conservative management

---

Surgical Technique: Posterior Fossa Decompression

Standard Procedure [19]

1. Suboccipital Craniectomy

   • Remove rim of occipital bone (foramen magnum decompression)
   • Size: typically 3-4cm diameter

2. C1 Laminectomy

   • Remove posterior arch of C1 (atlas)
   • Enlarges craniocervical junction

3. Duraplasty (Controversial—Two Approaches):

   • Extradural (Bony) Decompression Only:
     • Dura left intact
     • Lower complication rate (less CSF leak, infection)
     • May be sufficient in many cases
   • Intradural Decompression with Duraplasty:
     • Dura opened
     • Arachnoid dissected (controversial)
     • Dural patch placed (autologous pericranium, bovine pericardium, synthetic)
     • Greater CSF flow improvement
     • Higher risk of CSF leak, pseudomeningocele, infection

Surgical Debate: Whether to perform duraplasty remains controversial. Some surgeons favour extradural-only decompression to reduce complications, while others argue duraplasty is necessary for adequate CSF flow restoration. [19]

---

Outcomes of Posterior Fossa Decompression

Success Rates [10,19]

Factors Predicting Good Outcome

• Shorter duration of symptoms (less than 2 years)
• Predominant headache (vs. myelopathy)
• Younger age
• Smaller syrinx

Factors Predicting Poor Outcome

• Long-standing neurological deficit (> 5 years)
• Severe syringomyelia (> 50% cord diameter)
• Older age (> 60 years)
• Revision surgery

---

Complications of Surgery

---

Management of Syringomyelia

Primary Treatment: Treat the underlying Chiari malformation

• Posterior fossa decompression → restores CSF flow → syrinx drainage over time

Direct Syrinx Surgery (Rare)

• Syringosubarachnoid shunt: Tube drains syrinx into subarachnoid space
• Syringopleural shunt: Tube drains syrinx into pleural cavity
• Indications: Persistent or enlarging syrinx despite adequate posterior fossa decompression

Outcome: Syrinx typically stabilizes or reduces in 60-80% of cases following PFD, but improvement may take 6-24 months. [9,10]

---

Management of Chiari Type II

Hydrocephalus Management [7]

• VP shunt (ventriculoperitoneal shunt)—first-line treatment for hydrocephalus in Chiari II
• Placed in 80-90% of patients within first year of life
• Complications: shunt infection, obstruction, overdrainage

Myelomeningocele Repair

• Postnatal repair (traditional): Surgical closure within 24-48 hours of birth
• Fetal surgery (prenatal repair—MOMS trial) [18]:
  • In utero repair at 19-26 weeks gestation
  • "Benefits: Reduced need for VP shunt (40% vs 82%), improved motor outcomes"
  • "Risks: Preterm delivery, maternal complications (uterine dehiscence)"

Brainstem Decompression

• Controversial in infants (high complication rate)
• Reserved for severe, life-threatening symptoms (stridor, apnoea) not responding to VP shunt
• May require tracheostomy if vocal cord paralysis

Multidisciplinary Care

• Paediatric neurosurgery
• Spina bifida clinic (neurology, urology, orthopaedics, physiotherapy, occupational therapy)
• Lifelong follow-up

---

Conservative Management (Asymptomatic Chiari I)

Surveillance Protocol

• Baseline MRI: Document tonsillar descent, syrinx (if present)
• Repeat MRI:
  • At 1 year (first follow-up)
  • Then every 2-3 years if stable and asymptomatic
• Clinical review: Annual or if new symptoms
• Patient education: Symptoms to report (headache, weakness, sensory changes, dysphagia)

Lifestyle Advice

• Avoid high-impact activities (diving, contact sports) if syrinx present
• Avoid activities that involve repeated Valsalva (heavy weightlifting)
• No specific restrictions if truly asymptomatic

No Indication for Prophylactic Surgery

• Natural history studies show most asymptomatic patients remain stable [10]

---

10. Complications

Complications of Untreated Chiari Malformation

---

Complications of Posterior Fossa Decompression

Early Complications (Within 30 Days)

Late Complications (> 30 Days)

---

11. Prognosis and Outcomes

Natural History of Untreated Chiari I

Asymptomatic Patients

• 80-90% remain stable over 5-10 years [10]
• 10-20% develop symptoms (headache, syrinx progression)
• Progression is unpredictable—no reliable predictors identified

Symptomatic Patients

• Symptoms typically progress slowly over months to years
• Syringomyelia usually enlarges without treatment
• Spontaneous stabilisation or improvement is rare (less than 10%)

---

Prognosis After Posterior Fossa Decompression

Headache

• 70-85% experience improvement or resolution [10,19]
• Best outcome of all symptoms
• Improvement usually within 3-6 months

Syringomyelia

• 60-80% show stabilization or reduction on MRI [9,10]
• May take 6-24 months for syrinx to shrink
• Complete resolution is uncommon (30-40%)

Neurological Deficit

• 30-50% show improvement (strength, sensation)
• Established deficits may be irreversible (long-standing anterior horn cell loss, tract damage)
• Sensory loss tends to improve more than motor weakness

Sleep Apnoea

• 70-80% improve with decompression [15]

Overall Quality of Life

• 70-80% report satisfaction with surgery
• Younger patients and those with shorter symptom duration have better outcomes

---

Prognosis of Chiari Type II

Infant Mortality: 10-15% in first year of life (apnoea, brainstem dysfunction) [7]

Long-Term Survival

• Depends on severity of myelomeningocele, hydrocephalus, and associated comorbidities
• Many patients survive to adulthood with appropriate management
• Quality of life variable (mobility, continence, cognitive function)

Factors Predicting Poor Outcome

• High-level myelomeningocele (thoracic or high lumbar)
• Severe hydrocephalus requiring multiple shunt revisions
• Symptomatic brainstem compression in infancy
• Shunt infections

---

Long-Term Follow-Up

Recommended Follow-Up Schedule (Chiari I Post-Surgery)

• 6 months: Clinical review, repeat MRI (assess decompression, syrinx)
• 12 months: Repeat MRI (syrinx may continue to shrink)
• Annually thereafter: Clinical review; MRI if new symptoms

Indications for Repeat MRI

• New or worsening symptoms
• Concern for recurrent syrinx or inadequate decompression
• Pre-pregnancy counselling (women of childbearing age)

---

12. Prevention and Counselling

Primary Prevention (Chiari Type II / Neural Tube Defects)

Folic Acid Supplementation [13]

• Recommendation: All women of childbearing age should take 400-800 mcg folic acid daily
• Timing: Start before conception (ideally 3 months prior) and continue through first trimester
• Mechanism: Folate is essential for DNA synthesis and neural tube closure
• Evidence: Reduces risk of neural tube defects (spina bifida, anencephaly) by 50-70%
• High-risk groups (previous affected pregnancy, diabetes, anti-epileptic drugs): 5mg folic acid daily

Fortification of Food

• Many countries (USA, Canada, Australia) mandate folic acid fortification of flour and cereals
• Has led to dramatic reduction in NTD incidence

---

Genetic Counselling

Chiari Type I

• Mostly sporadic (no family history)
• Rare familial clustering (1-4% of cases) [14]
• Recurrence risk in siblings: low (less than 5%)
• If familial pattern suspected, consider referral to genetics

Chiari Type II (Myelomeningocele)

• Recurrence risk in subsequent pregnancies: 2-5%
• Higher if two previous affected pregnancies (10-15%)
• Prenatal screening: Maternal serum alpha-fetoprotein (MSAFP), detailed ultrasound, MRI

---

Pregnancy and Chiari Malformation

Pre-Pregnancy Counselling

• Women with known Chiari I should discuss pregnancy plans with neurology/neurosurgery
• Most women tolerate pregnancy well
• Symptoms may worsen due to:
  • Increased intra-abdominal pressure
  • Valsalva during labour (pushing)
  • Hormonal changes

Intrapartum Management

• Mode of delivery:
  • Vaginal delivery usually safe in asymptomatic or mildly symptomatic Chiari I
  • "Elective caesarean section considered if:"
    • Severe symptoms
    • Large syrinx
    • Recent posterior fossa decompression (less than 6 months)
• Anaesthetic considerations:
  • "Epidural/spinal anaesthesia: Generally safe if no large syrinx or recent surgery"
  • Discuss with obstetric anaesthetist
  • General anaesthesia may be preferred in complex cases

---

13. Multidisciplinary Team (MDT) Management

Chiari malformations require input from multiple specialties.

Core Team

Extended Team (Chiari Type II)

---

14. Examination Focus: Viva Questions and Model Answers

Question 1: Diagnostic Criteria

Examiner: "What is the radiological definition of Chiari I malformation?"

Model Answer: "Chiari I malformation is defined by cerebellar tonsillar descent of ≥5mm below the foramen magnum on sagittal T1 or T2 MRI. The landmark used is the McRae line, which connects the basion (anterior margin of foramen magnum) to the opisthion (posterior margin). However, it's important to note that the degree of descent does not correlate with symptom severity—some patients with 5mm descent are highly symptomatic, while others with 15mm descent are asymptomatic. Therefore, clinical correlation is essential."

---

Question 2: Pathophysiology of Syringomyelia

Examiner: "How does Chiari I malformation lead to syringomyelia?"

Model Answer: "The pathophysiology involves abnormal CSF dynamics at the craniocervical junction:

1. Tonsillar impaction at the foramen magnum acts as a 'cork-in-bottle,' obstructing the posterior subarachnoid space (cisterna magna is obliterated).

2. During cardiac systole, the brain expands, ejecting CSF into the spinal canal. However, the obstruction causes pressure dissociation—cranial CSF pressure exceeds spinal CSF pressure.

3. These abnormal pressure waves are transmitted to the spinal cord surface and drive fluid into the central canal (which normally obliterates after childhood).

4. Progressive fluid accumulation results in syrinx formation and expansion.

5. Successful posterior fossa decompression restores CSF flow, allowing the syrinx to drain over months to years."

---

Question 3: Management of Asymptomatic Chiari I

Examiner: "A 25-year-old woman has an incidental finding of 8mm tonsillar descent on MRI done for unrelated reasons. She is asymptomatic. How would you manage her?"

Model Answer: "This is an asymptomatic Chiari I malformation. My approach would be:

1. Confirm she is truly asymptomatic: Take a careful history to exclude subtle symptoms like mild occipital headache, Valsalva-triggered symptoms, or sensory disturbance.

2. Review the MRI: Check for presence of syringomyelia, which may influence management.

3. If truly asymptomatic:

   • I would not recommend surgery, as natural history studies show 80-90% of asymptomatic patients remain stable over years.
   • I would arrange surveillance MRI at 1 year to check for syrinx development, then every 2-3 years if stable.
   • I would provide patient education about symptoms to watch for (headache, weakness, sensory changes, dysphagia) and advise her to seek review if these develop.

4. Lifestyle advice: Avoid high-impact activities (diving, contact sports) and repeated Valsalva (heavy weightlifting) if syrinx develops.

5. Pre-pregnancy counselling if relevant: Discuss pregnancy risks (most tolerate pregnancy well, but symptoms may worsen; vaginal delivery usually safe)."

---

Question 4: Indications for Surgery

Examiner: "What are the indications for posterior fossa decompression in Chiari I malformation?"

Model Answer: "Posterior fossa decompression is indicated for symptomatic Chiari I. The key indications are:

1. Persistent, disabling headache (occipital, Valsalva-triggered) not responding to conservative measures

2. Progressive syringomyelia (enlarging cavity on serial MRI)

3. Neurological deficit:

   • Motor weakness (syrinx-related or myelopathy)
   • Dissociated sensory loss
   • Lower cranial nerve palsies

4. Brainstem compression symptoms:

   • Sleep apnoea (central or obstructive)
   • Dysphagia, aspiration risk
   • Downbeat nystagmus with functional impairment

5. Significant impairment of quality of life

Contraindications:

• Asymptomatic patients (observation only)
• Severe comorbidities precluding surgery
• Patient preference for conservative management"

---

Question 5: Differentiating Chiari I and II

Examiner: "How do Chiari I and Chiari II differ clinically and radiologically?"

Model Answer: "I'll compare them systematically:

The key distinction is that Chiari II is part of a triad: neural tube defect + hindbrain herniation + hydrocephalus, whereas Chiari I is typically isolated tonsillar herniation."

---

Question 6: Complications of Surgery

Examiner: "What are the main complications of posterior fossa decompression?"

Model Answer: "I'll categorize complications by timing:

Early Complications (within 30 days):

• CSF leak (5-15%): Most common complication; may require surgical repair
• Infection (2-5%): Meningitis or wound infection; requires antibiotics ± washout
• Pseudomeningocele (5-10%): Fluctuant swelling; most resolve with observation
• Neurological deterioration (1-5%): Due to haematoma, oedema, or inadequate decompression; requires urgent imaging
• Haematoma (1-2%): Extradural or subdural; may require evacuation

Late Complications (> 30 days):

• Recurrent symptoms (10-20%): May require revision decompression
• Craniocervical instability (less than 1%): Requires posterior fusion
• Hydrocephalus (less than 2%): May require VP shunt

Rare but Serious:

• Brainstem injury (less than 1%): May be permanent
• Death (less than 0.5%): Due to brainstem injury or infection

Overall, 70-80% of patients are satisfied with surgery, with headache showing the best improvement (70-85%)."

---

15. Patient/Layperson Explanation

What is a Chiari Malformation?

A Chiari malformation is a condition where part of your brain (the cerebellum, which sits at the back of your head) pushes down through the opening at the base of your skull into your spinal canal. This opening is called the foramen magnum.

Think of it like this: the skull is like a box that should contain the brain. In Chiari malformation, the box is slightly too small, so part of the brain gets squeezed out of the bottom opening.

---

What Are the Types?

There are different types, but the two most common are:

• Type I (Chiari I): This is the most common and usually found in adults. A small part of the cerebellum (called the tonsils—not the same as throat tonsils!) slips down slightly through the opening. Many people with this type have no symptoms at all and only find out by accident when they have an MRI scan for another reason.

• Type II (Chiari II): This is more severe and almost always occurs in babies born with spina bifida (a condition where the spinal cord doesn't develop properly). It causes more serious problems and is usually diagnosed before or soon after birth.

---

What Are the Symptoms?

Type I symptoms (if they occur) include:

• Headaches at the back of your head, especially when you cough, sneeze, or strain
• Neck pain
• Dizziness or balance problems
• Numbness or tingling in your hands (especially if you develop a fluid-filled cavity in your spinal cord called a syrinx)
• Weakness in your hands or legs
• Difficulty swallowing (if severe)

Type II symptoms (in babies) include:

• Difficulty breathing (noisy breathing, apnoea)
• Difficulty feeding
• Weak cry
• Enlarged head (due to fluid buildup—hydrocephalus)

---

How is it Diagnosed?

The main test is an MRI scan of your brain and spine. This shows:

• How far the brain tissue has dropped down
• Whether there's a fluid-filled cavity in your spinal cord (syrinx)
• Whether there's fluid buildup in the brain (hydrocephalus)

---

How is it Treated?

If you have no symptoms:

• You usually don't need treatment. Most people with no symptoms stay well.
• You'll have regular MRI scans (every 1-2 years) to check that things haven't changed.

If you have symptoms:

• You may need surgery called posterior fossa decompression.
• This operation removes a small piece of bone at the back of your skull and sometimes the top of your spine to create more space for your brain.
• About 70-80% of people feel better after surgery, especially if your main symptom is headache.

For babies with Type II:

• They usually need a shunt (a tube that drains extra fluid from the brain).
• Some may need surgery to create more space at the back of the skull if they have breathing or swallowing problems.

---

What is the Outlook?

• Type I: If you have surgery, most people (70-80%) notice improvement in their symptoms, especially headaches. The fluid-filled cavity in the spine (syrinx) often shrinks over time, but this can take months to years.

• Type II: This depends on how severe the spina bifida is and whether there are other complications. Many children with Chiari II grow up to live fulfilling lives with the right support and treatment.

---

What Should I Do if I Have Symptoms?

If you have been told you have a Chiari malformation and you develop:

• New or worsening headaches
• Weakness or numbness in your arms or legs
• Difficulty swallowing or breathing
• Changes in balance or coordination

You should see your doctor urgently or contact your neurosurgeon.

---

16. Key Guidelines and Evidence

Guidelines

1. American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS): Guideline for the Diagnosis and Management of Patients with Chiari I Malformation

   • Recommends MRI as gold standard
   • Surgery for symptomatic patients only
   • No consensus on duraplasty vs extradural-only decompression

2. NICE (National Institute for Health and Care Excellence): Suspected Neurological Conditions: Recognition and Referral (NG127)

   • Cough headache should prompt urgent MRI referral
   • Refer to neurosurgery if symptomatic Chiari confirmed

3. Spina Bifida Association (USA): Guidelines for the Care of People with Spina Bifida

   • Multidisciplinary management of Chiari II
   • VP shunt for hydrocephalus
   • Monitor for brainstem symptoms

---

Landmark Studies

Chiari I Epidemiology and Natural History

1. Meadows et al. (2000) [1]

   • Large retrospective MRI study: tonsillar ectopia ≥5mm in 0.77% of scans
   • Established 5mm threshold for diagnosis
   • PMID: 10919884

2. Strahle et al. (2011) [10]

   • Natural history of asymptomatic Chiari I: 80% remain stable over 3 years
   • No indication for prophylactic surgery
   • PMID: 21780863

Surgical Outcomes

3. Aliaga et al. (2012) [19]

   • Meta-analysis of posterior fossa decompression: 70-85% headache improvement
   • Duraplasty vs bony-only decompression: no clear superiority
   • PMID: 22525563

4. Durham and Fjeld-Olenec (2008) [9]

   • Syringomyelia outcomes: 60-80% stabilization or reduction post-PFD
   • Mean time to syrinx reduction: 12-18 months
   • PMID: 18358024

Chiari II and Fetal Surgery

5. Adzick et al. (2011) - MOMS Trial [18]
   • Landmark RCT: prenatal vs postnatal myelomeningocele repair
   • Prenatal repair reduced VP shunt requirement (40% vs 82%)
   • Improved motor outcomes at 30 months
   • PMID: 21306277

Sleep Apnoea

6. Ferré et al. (2017) [15]
   • Sleep apnoea in 30% of Chiari I patients (central and obstructive)
   • 70-80% improvement post-decompression
   • PMID: 28414061

---

17. References

1. Meadows J, Kraut M, Guarnieri M, et al. Asymptomatic Chiari Type I malformations identified on magnetic resonance imaging. J Neurosurg. 2000;92(6):920-926. doi:10.3171/jns.2000.92.6.0920

2. Barkovich AJ, Wippold FJ, Sherman JL, et al. Significance of cerebellar tonsillar position on MR. AJNR Am J Neuroradiol. 1986;7(5):795-799. PMID: 3096099

3. Tubbs RS, Iskandar BJ, Bartolucci AA, Oakes WJ. A critical analysis of the Chiari 1.5 malformation. J Neurosurg. 2004;101(2 Suppl):179-183. doi:10.3171/ped.2004.101.2.0179

4. Caldarelli M, Novegno F, Vassimi L, et al. The role of limited posterior fossa craniectomy in the surgical treatment of Chiari malformation Type I: experience with a pediatric series. J Neurosurg Pediatr. 2007;106(3):187-195. doi:10.3171/ped.2007.106.3.187

5. Nishikawa M, Sakamoto H, Hakuba A, et al. Pathogenesis of Chiari malformation: a morphometric study of the posterior cranial fossa. J Neurosurg. 1997;86(1):40-47. doi:10.3171/jns.1997.86.1.0040

6. Milhorat TH, Chou MW, Trinidad EM, et al. Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery. 1999;44(5):1005-1017. doi:10.1097/00006123-199905000-00042

7. Stevenson KL. Chiari Type II malformation: past, present, and future. Neurosurg Focus. 2004;16(2):E5. doi:10.3171/foc.2004.16.2.6

8. Pascual J, Iglesias F, Oterino A, et al. Cough, exertional, and sexual headaches: an analysis of 72 benign and symptomatic cases. Neurology. 1996;46(6):1520-1524. doi:10.1212/wnl.46.6.1520

9. Durham SR, Fjeld-Olenec K. Comparison of posterior fossa decompression with and without duraplasty for the surgical treatment of Chiari malformation Type I in pediatric patients: a meta-analysis. J Neurosurg Pediatr. 2008;2(1):42-49. doi:10.3171/PED/2008/2/7/042

10. Strahle J, Muraszko KM, Kapurch J, et al. Natural history of Chiari malformation Type I following decision for conservative treatment. J Neurosurg Pediatr. 2011;8(2):214-221. doi:10.3171/2011.4.PEDS10298

11. Hain TC, Helminski JO, Reis IL, Uddin MK. Vibration does not improve results of the Dix-Hallpike test. Ear Nose Throat J. 2000;79(8):584-590. PMID: 10969466

12. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821-1828. doi:10.1056/NEJMoa070972

13. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338(8760):131-137. doi:10.1016/0140-6736(91)90133-a

14. Boyles AL, Enterline DS, Hammock PH, et al. Phenotypic definition of Chiari type I malformation coupled with high-density SNP genome screen shows significant evidence for linkage to regions on chromosomes 9 and 15. Am J Med Genet A. 2006;140(24):2776-2785. doi:10.1002/ajmg.a.31546

15. Ferré A, Poca MA, de la Calzada MD, et al. Sleep-related breathing disorders in Chiari malformation type 1: a prospective study of 90 patients. Sleep. 2017;40(6). doi:10.1093/sleep/zsx069

16. McLone DG, Knepper PA. The cause of Chiari II malformation: a unified theory. Pediatr Neurosci. 1989;15(1):1-12. doi:10.1159/000120432

17. Chaoui R, Benoit B, Mitkowska-Wozniak H, et al. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan. Ultrasound Obstet Gynecol. 2009;34(3):249-252. doi:10.1002/uog.7329

18. Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364(11):993-1004. doi:10.1056/NEJMoa1014379

---